Skip to main content
HNF
Molecular Diagnosis in NETs
Accurate anatomic subtyping, optimal diagnostic imaging, and molecular classification are among the most pressing needs with NETs.
Read More
HNF
PRRT—Pushing the Limits and New Directions
The future of PRRT lies in its use in combination therapies, including PRRT with chemotherapy, immunotherapy, and as neoadjuvant/adjuvant therapy with surgery.
Read More
HNF
Extending PRRT: Targeted Alpha-Emitter Radionuclide Therapy of NETs
Targeted alpha-particle therapy is in development for targeted radionuclide therapy of NETs, employing alpha decay to treat diseased tissue at close proximity.
Read More
HNF
Telotristat for Diarrhea Associated with Carcinoid Syndrome
Telotristat ethyl is safe and effective in reducing intractable diarrhea in patients with carcinoid syndrome.
Read More
HNF
Expert Perspectives on Further Research Needed in NETs
An expert working group developed specific ideas for future research programs in NETs, as well as ways to improve access to NET clinical trials.
Read More

Results 1 - 5 of 5